Page last updated: 2024-10-27

fexofenadine and Dermatitis

fexofenadine has been researched along with Dermatitis in 2 studies

fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.

Dermatitis: Any inflammation of the skin.

Research Excerpts

ExcerptRelevanceReference
"In vivo antihistaminic activity experiments consisted of measurement of: inhibition of increase in capillary permeability and reduction in microvascular extravasation and bronchospasm in rats and guinea pigs induced by histamine and other inflammatory mediators; and protection against lethality induced by histamine and other inflammatory mediators in rats."3.73In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist. ( Berisa, A; Corcóstegui, R; Innerárity, A; Labeaga, L; Orjales, A, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dall'Agnol, B1
Schott, D1
Padilha, T1
Antunes, P1
Souza, UA1
Webster, A1
Souza, GD1
Ferreira, CAS1
Reck, J1
Corcóstegui, R1
Labeaga, L1
Innerárity, A1
Berisa, A1
Orjales, A1

Other Studies

2 other studies available for fexofenadine and Dermatitis

ArticleYear
Clinical Findings Associated with Ornithodoros brasiliensis Tick Parasitism in Travelers, Southern Brazil.
    Wilderness & environmental medicine, 2019, Volume: 30, Issue:4

    Topics: Animals; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Brazil; Dermatitis;

2019
In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
    Drugs in R&D, 2006, Volume: 7, Issue:4

    Topics: Animals; Benzimidazoles; Bradykinin; Bronchial Spasm; Capillary Permeability; Cetirizine; Dermatitis

2006